Polku Therapeutics
ID: 17747743Polku Therapeutics is a small molecule drugs manufacturer for neurodegenerative diseases founded in 2023 by Simon Bennett, Sebastian Soidinsalo, Timo Myöhänen and Docent Erik Wallén.
1
Funding Rounds
$2.3m
Money raised
Recent Funding Rounds
Overview
Polku Therapeutics is a small molecule drugs manufacturer for neurodegenerative diseases founded in 2023 by Simon Bennett, Sebastian Soidinsalo, Timo Myöhänen and Docent Erik Wallén.
- Website:
- Business model: B2C
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti** My******** |
|
- | - |
| Si*** Be***** |
|
- | - |
| Do**** Er** Wa***** | - | - | - |
| Se******* So******** |
|
- |
Funding series
Funding Series Analysis
The company Polku Therapeutics has raised a total of $2.3m in funding over 1 rounds.
Key Insights:
- Polku Therapeutics Pre-Seed Round, September 2024: $2.3m